BIOMAT Database Logo BIOMAT Database Logo

Hyperuricemia and Cardiovascular Disease in Patients with Hypertension. 2016

Andres Acevedo, and Julian Benavides, and Mohsin Chowdhury, and Mabel Lopez, and Laura Pena, and Ana Montenegro, and Marta Lievano, and Bernardo Lombo

BACKGROUND Little is known about the role of serum uric acid in cardiovascular events. We studied the prevalence of hyperuricemia and the association between uric acid level and various cardiovascular risk factors. METHODS This cross-sectional study was based on a population of patients with hypertension who attended a hypertension clinic in a university hospital in Bogotá, Colombia. Bivariate analysis and multivariate logistic regression models were utilized to investigate the relationship between hyperuricemia and cardiovascular risk factors. RESULTS The study population included 444 patients. The overall prevalence of hyperuricemia was 28.8%. Male gender (OR 2.3), age (OR 1.03), BMI (OR 1.09), triglyceride level (OR 1.005) and low HDL (OR 0.96) were significantly associated with hyperuricemia. CONCLUSIONS Prevalence of hyperuricemia is high in patients with hypertension. Serum uric acid is significantly associated with parameters of the metabolic syndrome. Hyperuricemia should be acknowledged and monitored as a risk factor for cardiovascular disease.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003105 Colombia A country in northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the north Pacific Ocean, between Ecuador and Panama. The capital is Bogota.
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Andres Acevedo, and Julian Benavides, and Mohsin Chowdhury, and Mabel Lopez, and Laura Pena, and Ana Montenegro, and Marta Lievano, and Bernardo Lombo
Hyperuricemia, Cardiovascular Disease, and Hypertension.
April 2016, Pulse (Basel, Switzerland),
Andres Acevedo, and Julian Benavides, and Mohsin Chowdhury, and Mabel Lopez, and Laura Pena, and Ana Montenegro, and Marta Lievano, and Bernardo Lombo
Systolic hypertension, hyperuricemia, and hyperglycemia as risk factors in cardiovascular disease.
March 1976, The Journal of the Medical Society of New Jersey,
Andres Acevedo, and Julian Benavides, and Mohsin Chowdhury, and Mabel Lopez, and Laura Pena, and Ana Montenegro, and Marta Lievano, and Bernardo Lombo
Hyperuricemia and Cardiovascular Disease.
January 2019, Current pharmaceutical design,
Andres Acevedo, and Julian Benavides, and Mohsin Chowdhury, and Mabel Lopez, and Laura Pena, and Ana Montenegro, and Marta Lievano, and Bernardo Lombo
Hyperuricemia and Cardiovascular Disease.
January 2017, Reviews in cardiovascular medicine,
Andres Acevedo, and Julian Benavides, and Mohsin Chowdhury, and Mabel Lopez, and Laura Pena, and Ana Montenegro, and Marta Lievano, and Bernardo Lombo
[Hyperuricemia and kidney damage in patients with cardiovascular disease: A review].
January 2023, Terapevticheskii arkhiv,
Andres Acevedo, and Julian Benavides, and Mohsin Chowdhury, and Mabel Lopez, and Laura Pena, and Ana Montenegro, and Marta Lievano, and Bernardo Lombo
[Hyperuricemia in patients with essential hypertension].
December 1985, Zhonghua nei ke za zhi,
Andres Acevedo, and Julian Benavides, and Mohsin Chowdhury, and Mabel Lopez, and Laura Pena, and Ana Montenegro, and Marta Lievano, and Bernardo Lombo
Hyperuricemia and cardiovascular disease risk.
October 2014, Expert review of cardiovascular therapy,
Andres Acevedo, and Julian Benavides, and Mohsin Chowdhury, and Mabel Lopez, and Laura Pena, and Ana Montenegro, and Marta Lievano, and Bernardo Lombo
Hypertension, hyperuricemia and iatrogenic disease.
August 1970, The American journal of medicine,
Andres Acevedo, and Julian Benavides, and Mohsin Chowdhury, and Mabel Lopez, and Laura Pena, and Ana Montenegro, and Marta Lievano, and Bernardo Lombo
Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
February 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Andres Acevedo, and Julian Benavides, and Mohsin Chowdhury, and Mabel Lopez, and Laura Pena, and Ana Montenegro, and Marta Lievano, and Bernardo Lombo
Hyperuricemia as a Risk Factor in Hypertension among Patients with Very High Cardiovascular Risk.
September 2023, Healthcare (Basel, Switzerland),
Copied contents to your clipboard!